P
3.47
-0.09 (-2.53%)
| Previous Close | 3.56 |
| Volume | 4,223,250 |
| Price / Sales | 151.10 |
| Price / Book | 0.320 |
| 52 Weeks Range |
| Operating Margin (TTM) | -3,603.30% |
| Diluted EPS (TTM) | -1.61 |
| Quarterly Revenue Growth (YOY) | 146.00% |
| Total Debt/Equity (MRQ) | 113.31% |
| Current Ratio (MRQ) | 4.78 |
| Operating Cash Flow (TTM) | -104.02 M |
| Levered Free Cash Flow (TTM) | -106.25 M |
| Return on Assets (TTM) | -40.36% |
| Return on Equity (TTM) | -115.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Prime Medicine, Inc. | Mixed | Mixed |
AIStockmoo Score
0.0
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
|
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 24.22% |
| % Held by Institutions | 56.84% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Casdin Capital, Llc | 30 Jun 2026 | 3,167,175 |
| Amova Asset Management Americas, Inc. | 30 Jun 2026 | 2,407,018 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |